1. [1] Chatfield, S.N. and Dougan, G. (1997) Attenuated Salmonella as a live vector for expression of foreign antigens. Part i. Expressing bacterial antigens. In: New Generation Vaccines (Levine, M.M., et al., Eds.), 2nd edn., pp. 331â341. Marcel Dekker, New York.
2. Recombinant Salmonella vectors in vaccine development;Curtiss;Dev. Biol. Stand.,1994
3. [3] Hormaeche, C.E., Khan, C.M.A., Mastroeni, P., Villarreal, B., Dougan, B., Roberts, M. and Chatfield, S.N. (1995) Salmonella vaccines: mechanisms of immunity and their use as carriers of recombinant antigens. In: Molecular and Clinical Aspects of Vaccine Development (AlaâAldeen, D. and Hormaeche, C.E., Eds.), pp. 119â153. John Wiley, Chichester.
4. [4] Hormaeche, C.E. and Khan, C.M.A. (1996) Recombinant bacteria as vaccine carriers of heterologous antigens. In: Concepts in Vaccine Development (Kaufmann, S.H.E., Ed.), pp. 327â349. W. de Gruyter, Berlin.
5. [5] Levine, M.M., Tacket, C.O., Galen, J.E., Barry, E.M., Noriega, F. and Sztein, M.B. (1997) Progress in development of new attenuated strains of Salmonella typhi as live oral vaccines against typhoid fever. In: New Generation Vaccines (Levine, M.M., et al., Eds.), 2nd edn, pp. 437â446. Marcel Dekker, New York.